当前位置：
X-MOL 学术
›
Lett. Appl. Microbiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Probiotics and COVID‐19: is there any link?
Letters in Applied Microbiology ( IF 2.0 ) Pub Date : 2020-07-16 , DOI: 10.1111/lam.13334 A Akour 1, 2
Letters in Applied Microbiology ( IF 2.0 ) Pub Date : 2020-07-16 , DOI: 10.1111/lam.13334 A Akour 1, 2
Affiliation
|
Abstract Understanding mechanisms of the novel SARS‐CoV2 infection and progression, can provide potential novel targets for prevention and/or treatment. This could be achieved via the inhibition of viral entry and/or replication, or by suppression the immunologic response that is provoked by the infection (known as the cytokine storm). Probiotics are defined as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host”. There is scarcity of evidence about the relationship between COVID‐19 and gut microbiota. So, whether or not these supplements can prevent or ameliorate COVID‐19 associated symptoms is not fully understood. The aim of this paper is to provide an indirect evidence about the utility of probiotics in combating COVID‐19 or its associated symptoms, through the review of its antiviral and anti‐inflammatory properties in vitro, animal models, and human trials.
中文翻译：
益生菌和 COVID-19：有什么联系吗？
摘要 了解新型 SARS-CoV2 感染和进展的机制，可以为预防和/或治疗提供潜在的新靶点。这可以通过抑制病毒进入和/或复制，或通过抑制由感染引起的免疫反应（称为细胞因子风暴）来实现。益生菌被定义为“活的微生物，当摄入足够的量时，会给宿主带来健康益处”。缺乏关于 COVID-19 与肠道微生物群之间关系的证据。因此，这些补充剂是否可以预防或改善 COVID-19 相关症状尚不完全清楚。本文的目的是提供关于益生菌在对抗 COVID-19 或其相关症状中的效用的间接证据，
更新日期：2020-07-16
中文翻译：
益生菌和 COVID-19：有什么联系吗？
摘要 了解新型 SARS-CoV2 感染和进展的机制，可以为预防和/或治疗提供潜在的新靶点。这可以通过抑制病毒进入和/或复制，或通过抑制由感染引起的免疫反应（称为细胞因子风暴）来实现。益生菌被定义为“活的微生物，当摄入足够的量时，会给宿主带来健康益处”。缺乏关于 COVID-19 与肠道微生物群之间关系的证据。因此，这些补充剂是否可以预防或改善 COVID-19 相关症状尚不完全清楚。本文的目的是提供关于益生菌在对抗 COVID-19 或其相关症状中的效用的间接证据，
京公网安备 11010802027423号